Literature DB >> 2142640

Increased elastase secretion by peripheral blood monocytes in cystic fibrosis patients.

M M Jones1, D K Seilheimer, G B Pier, R D Rossen.   

Abstract

Morbidity and mortality in cystic fibrosis (CF) is predominantly due to destruction of pulmonary tissue. The host immune response may, in part, play a pathogenic role in pulmonary destruction in these patients. To further understand host immune response in CF, we examined the state of activation of peripheral blood monocytes in CF. Baseline elastase activity was 2.2-fold greater in the CF monocytes than in controls. Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and high molecular weight polysaccharide (HMP) increased elastase activity in both control and CF monocytes, with a greater absolute increase in the CF monocytes. There was no difference in baseline or MEP-stimulated secretion of interleukin-1 (IL-1) or interleukin-6 (IL-6) between CF and control monocytes. Ibuprofen enhanced both MEP and HMP-stimulated elastase activity, whereas dexamethasone suppressed both baseline and stimulated elastase activity greater than 20% in both CF and control monocytes. These results suggest that circulating monocytes in CF are stimulated in vivo, resulting in a remarkably elevated elastase activity in vitro. Elevated elastase release by peripheral blood monocytes as they enter the lung in response to chemotactic stimuli may contribute to lung destruction in CF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2142640      PMCID: PMC1535195          DOI: 10.1111/j.1365-2249.1990.tb03290.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

Authors:  S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  Single step separation of human T and B cells using AET treated srbc rosettes.

Authors:  A Saxon; J Feldhaus; R A Robins
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

3.  Isolation and characterization of a high-molecular-weight polysaccharide from the slime of Pseudomonas aeruginosa.

Authors:  G B Pier; H F Sidberry; S Zolyomi; J C Sadoff
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

4.  Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis.

Authors:  S Suter; U B Schaad; L Roux; U E Nydegger; F A Waldvogel
Journal:  J Infect Dis       Date:  1984-04       Impact factor: 5.226

Review 5.  Diagnosis and treatment of cystic fibrosis. An update.

Authors:  P B Davis; P A di Sant'Agnese
Journal:  Chest       Date:  1984-06       Impact factor: 9.410

6.  Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study.

Authors:  W B Wheeler; M Williams; W J Matthews; H R Colten
Journal:  J Pediatr       Date:  1984-05       Impact factor: 4.406

7.  Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.

Authors:  H A Chapman; O L Stone; Z Vavrin
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

8.  Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa.

Authors:  G B Pier; W J Matthews; D D Eardley
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

9.  Polyclonal B cell stimulation and interleukin 1 induction by the mucoid exopolysaccharide of Pseudomonas aeruginosa associated with cystic fibrosis.

Authors:  L Daley; G B Pier; J D Liporace; D D Eardley
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

10.  IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis.

Authors:  R B Fick; R S Baltimore; S U Squier; H Y Reynolds
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

View more
  4 in total

1.  Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions.

Authors:  Caroline N Jones; Jesmond Dalli; Laurie Dimisko; Elisabeth Wong; Charles N Serhan; Daniel Irimia
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

2.  Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes.

Authors:  R B Moss; Y P Hsu; L Olds
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

Review 3.  Cystic Fibrosis Lung Immunity: The Role of the Macrophage.

Authors:  Emanuela M Bruscia; Tracey L Bonfield
Journal:  J Innate Immun       Date:  2016-06-24       Impact factor: 7.349

4.  Rescue from Pseudomonas aeruginosa Airway Infection via Stem Cell Transplantation.

Authors:  Kerstin Brinkert; Silke Hedtfeld; Annina Burhop; Rena Gastmeier; Pauline Gad; Dirk Wedekind; Christina Kloth; Justin Rothschuh; Nico Lachmann; Miriam Hetzel; Adan Chari Jirmo; Elena Lopez-Rodriguez; Christina Brandenberger; Gesine Hansen; Axel Schambach; Mania Ackermann; Burkhard Tümmler; Antje Munder
Journal:  Mol Ther       Date:  2020-12-03       Impact factor: 11.454

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.